Avinger (NASDAQ:AVGR) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the medical device company’s stock.

Separately, HC Wainwright reissued a buy rating and set a $5.00 target price on shares of Avinger in a report on Thursday, March 21st.

Avinger Stock Performance

Shares of NASDAQ:AVGR opened at $1.90 on Thursday. Avinger has a 52-week low of $1.59 and a 52-week high of $18.00. The company has a market capitalization of $3.23 million, a PE ratio of -0.10 and a beta of 1.12. The company has a fifty day moving average of $2.83 and a 200-day moving average of $3.01.

Avinger (NASDAQ:AVGR) last posted its earnings results on Wednesday, May 15th. The medical device company reported ($2.49) EPS for the quarter, missing the consensus estimate of ($1.35) by ($1.14). The business had revenue of $1.86 million during the quarter, compared to analysts’ expectations of $2.36 million. On average, equities analysts forecast that Avinger will post -2.08 EPS for the current fiscal year.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.